Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

Bridget Foley was diagnosed with diabetes as a teenager, but now the 33-year-old says she's struggling to keep up with her treatment in the cost-of-living crisis."I often skip out on going to medical ...

A new study reveals that diabetes rates have surged, with over 800 million adults globally having diabetes, and alarming ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more than half of those aged over 30 who have the condition are not receiving ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...

treatment, or life circumstance occurs. But, with few diabetes care teams having a health-care professional qualified in mental health, these recommendations are often unmet in clinical practice, ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...